Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Solvency Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Solvency Ratios (Summary)

Baxter International Inc., solvency ratios (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012
Debt Ratios
Debt to equity
Debt to capital
Debt to assets
Financial leverage

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).


The analysis of the financial leverage and debt-related ratios over the examined periods reveals several distinct trends and fluctuations.

Debt to Equity Ratio
The debt to equity ratio initially showed a gradual increase from 0.77 to 0.85 between March and December 2012. It further increased sharply to a peak of 1.78 in June 2015, indicating a higher proportion of debt relative to equity during that period. Subsequently, there was a significant decline to 0.37 by June 2016, suggesting a substantial reduction in reliance on debt financing relative to equity in the most recent periods.
Debt to Capital Ratio
Debt to capital ratio followed a similar trajectory, rising from 0.44 at the start of the analysis to a peak of 0.64 in June 2015. This denotes an increased share of debt in the total capital structure. In the following quarters, this ratio decreased markedly to 0.27 by June 2016, aligning with the trend observed in debt to equity ratio, reflecting deleveraging efforts or repayment of debt.
Debt to Assets Ratio
The debt to assets ratio demonstrated a more moderate increase from 0.28 in early 2012 to 0.47 in June 2015, indicating a growing proportion of liabilities relative to total assets. Post mid-2015, this ratio decreased to about 0.20 by the middle of 2016, showing improved asset coverage and reduced risk exposure related to the company’s liabilities.
Financial Leverage Ratio
The financial leverage ratio, representing the ratio of total assets to equity, also increased from 2.79 to a peak of 3.76 in June 2015, which suggests greater use of debt to finance assets during this phase. After this peak, the ratio declined to below 2, reaching 1.88 by June 2016, which corroborates the overall pattern of reduced leverage and risk mitigation through lower debt levels relative to equity following mid-2015.

Overall, the period analyzed shows a phase of increasing leverage culminating around mid-2015, followed by a notable deleveraging trend leading into 2016. This indicates a strategic shift toward lower debt dependency and possibly more conservative financial risk management in the recent periods.


Debt Ratios


Debt to Equity

Baxter International Inc., debt to equity calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012
Selected Financial Data (US$ in millions)
Short-term debt
Current maturities of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current maturities
Total debt
 
Total Baxter shareholders’ equity
Solvency Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).

1 Q2 2016 Calculation
Debt to equity = Total debt ÷ Total Baxter shareholders’ equity
= ÷ =

2 Click competitor name to see calculations.


Total Debt
The total debt showed relatively stable values in the periods from early 2012 through early 2013, ranging between approximately $5.2 billion and $5.9 billion. There was a notable increase during mid-2013, peaking near $14.2 billion by mid-2015. After this peak, total debt declined sharply, dropping to around $3.2 billion by mid-2016. This pattern indicates a significant accumulation of debt in the 2013-2015 period, followed by a rapid reduction phase.
Total Shareholders’ Equity
Total shareholders’ equity remained fairly stable during 2012, fluctuating between approximately $6.5 billion and $7.1 billion. From mid-2013 through 2014, equity increased gradually, reaching close to $8.7 billion at the end of 2013 and maintaining a level above $8 billion through 2014. However, there was a decline in equity around the first quarter of 2015, falling to about $7.3 billion before recovering to nearly $8.8 billion by late 2015 and early 2016. By mid-2016, equity slightly decreased again to around $8.5 billion. The trend suggests moderate equity growth with some volatility during the 2015 period.
Debt to Equity Ratio
The debt to equity ratio remained below 1.0 for the early periods of 2012, rising gradually to 0.85 by year-end 2012. There was a sharp increase beginning in early 2013, reaching a peak ratio of approximately 1.78 by mid-2015. This indicates that debt grew faster than equity during this time. After this peak, the ratio decreased significantly, falling below 0.4 by mid-2016, signaling a strong improvement in the company’s leverage position due to debt reduction and relatively stable equity levels.
Summary
The data shows a period of heightened leverage from 2013 through mid-2015, characterized by a marked increase in total debt and a corresponding rise in the debt to equity ratio exceeding 1.0, indicating debt levels surpassing equity. Following this period, the company actively reduced its total debt substantially while maintaining relatively stable equity, which led to a significant decline in the debt to equity ratio below 0.4 by mid-2016. Overall, these trends demonstrate a strategic shift from increased borrowing to deleveraging and enhanced financial stability in the most recent periods observed.

Debt to Capital

Baxter International Inc., debt to capital calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012
Selected Financial Data (US$ in millions)
Short-term debt
Current maturities of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current maturities
Total debt
Total Baxter shareholders’ equity
Total capital
Solvency Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).

1 Q2 2016 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Click competitor name to see calculations.


Total Debt
The total debt exhibited fluctuations over the observed periods. It initially increased from approximately $5.2 billion to around $9.2 billion between early 2012 and late 2014, peaking notably in the first half of 2015 at over $14.2 billion. However, from mid-2015 onward, there was a marked reduction in total debt, declining steadily to approximately $3.2 billion by mid-2016. This pattern indicates a period of increased leverage followed by a considerable deleveraging effort.
Total Capital
Total capital demonstrated a general upward trend from early 2012 through mid-2015, growing from roughly $11.9 billion to over $22.2 billion. After peaking in mid-2015, total capital contracted in the following periods, declining to about $11.7 billion by mid-2016. This contraction aligns with the observed reduction in total debt, suggesting an overall decrease in capital structure size.
Debt to Capital Ratio
The debt to capital ratio reflected changes in the balance between debt and total capital. Starting near 0.44 in early 2012, the ratio climbed gradually to a peak of 0.64 in mid-2015, indicating increased reliance on debt financing during this time. Following this peak, the ratio decreased sharply, reaching approximately 0.27 by mid-2016. This suggests a significant shift towards lower leverage and possibly stronger capitalization.

Debt to Assets

Baxter International Inc., debt to assets calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012
Selected Financial Data (US$ in millions)
Short-term debt
Current maturities of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current maturities
Total debt
 
Total assets
Solvency Ratio
Debt to assets1
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).

1 Q2 2016 Calculation
Debt to assets = Total debt ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


The financial data reveals notable variations in the company’s debt and asset positions over the analyzed quarters. The total debt experienced fluctuations, with initial values around $5.2 billion to $5.9 billion in 2012, followed by a significant increase peaking at $14.2 billion in the second quarter of 2015, before sharply declining to approximately $3.2 billion by the second quarter of 2016.

Total assets demonstrated a generally rising trend from about $18.8 billion at the beginning of 2012 to an apex of around $30 billion in mid-2015. Subsequently, asset levels decreased markedly to below $16 billion by mid-2016, indicating a contraction in the asset base during this period.

The debt-to-assets ratio depicts important insights into leverage trends. Initially, the ratio was relatively stable at around 0.28 to 0.30 through the first year. From mid-2013, there was an upward trend reaching nearly 0.47 in mid-2015, coinciding with the peak in total debt and assets. Following this peak, the ratio decreased substantially to approximately 0.20 by the middle of 2016, reflecting both the sharp debt reduction and asset base contraction.

Total Debt
The data indicates periods of significant borrowing followed by aggressive debt reduction. Notably, the surge in debt in 2015 stands out, doubling approximately compared to prior levels, which may suggest strategic financing actions during this time.
Total Assets
Assets accumulated over the period through to mid-2015, suggesting investment or acquisition activity. The subsequent decline in assets along with debt reduction could imply divestiture or the realization of assets to deleverage the balance sheet.
Debt to Assets Ratio
A rising leverage ratio peaking near 0.47 indicates increased financial risk or reliance on debt financing in 2015. The sharp post-peak decline to around 0.20 suggests a shift towards a more conservative capital structure by mid-2016, potentially improving credit risk profiles.

Overall, the data portrays a phase of expansion financed by increased debt, followed by a pronounced deleveraging and asset reduction phase. This pattern suggests a tactical adjustment in the company’s capital strategy, possibly responding to market conditions or internal financial objectives aimed at reducing leverage and strengthening the balance sheet stability.


Financial Leverage

Baxter International Inc., financial leverage calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012
Selected Financial Data (US$ in millions)
Total assets
Total Baxter shareholders’ equity
Solvency Ratio
Financial leverage1
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31).

1 Q2 2016 Calculation
Financial leverage = Total assets ÷ Total Baxter shareholders’ equity
= ÷ =

2 Click competitor name to see calculations.


The analysis of the quarterly financial data reveals several significant trends in the company's asset base, equity position, and financial leverage over the observed periods between March 2012 and June 2016.

Total Assets
The company's total assets exhibited an overall upward trend from March 2012 through mid-2015, increasing from approximately $18.8 billion to a peak of around $30 billion in June 2015. This growth suggests an expansion phase or asset accumulation during this period. However, from June 2015 to June 2016, a marked decline in total assets is observed, dropping sharply to about $16 billion. This decline could indicate asset divestitures, depreciation, or other balance sheet contractions.
Total Baxter Shareholders’ Equity
Shareholders’ equity showed moderate growth from $6.7 billion in March 2012 to a peak near $9 billion in March 2016. The equity base generally increased in a steady manner with minor fluctuations until early 2016. Despite the volatility in total assets towards mid-2015 to mid-2016, equity remained relatively stable though with a slight decrease post-March 2016, indicating resilience in the equity structure or limited impact from the asset reductions on shareholder equity.
Financial Leverage
The financial leverage ratio, which measures the level of assets funded by equity, reflects notable variability. The ratio fluctuated between roughly 2.7 and 3.8 during the initial phase (2012 to mid-2015), indicating a relatively high and somewhat volatile use of debt or other liabilities to finance assets. The ratio reached its highest values in late 2014 through mid-2015, coinciding with the peak in total assets. Thereafter, a significant decline in financial leverage is observed, moving down from about 3.76 in mid-2015 to below 2.0 by June 2016. This reduction suggests a deleveraging process occurred, potentially through reducing liabilities or managing asset levels more conservatively.

In summary, the data portrays a period of expansion in asset and equity size, accompanied by increased financial leverage up to mid-2015, followed by a contraction phase with lower asset levels and a notable reduction in leverage ratios through mid-2016. These shifts may reflect strategic changes in capital structure and asset management within the company during the period examined.